top of page


Abbott receives FDA approval and CE mark for UltiSynq conduction-system defibrillation lead
Abbott has secured US FDA approval and European CE marking for its UltiSynq defibrillation lead, combining conduction-system pacing capabilities with implantable defibrillator therapy.

nuaxia
49 minutes ago2 min read


FDA approves new CardioMEMS patient-facing capabilities for remote heart failure management
The FDA has approved new patient-facing CardioMEMS HF System capabilities that allow people with heart failure to view pulmonary artery pressure readings and receive personalised treatment updates.

nuaxia
Oct 62 min read


FDA approves Abbott TactiFlex Duo dual-energy ablation catheter for atrial fibrillation
The FDA has approved Abbott's TactiFlex Duo Ablation Catheter, a dual-energy system combining pulsed-field ablation and radiofrequency energy for the treatment of atrial fibrillation.

nuaxia
Sep 92 min read
bottom of page